Delivery Order SPE2DB22D2006-SPE2DB25FV7GG

Award Date 12/23/24
Potential Completion Date 12/24/24
Potential Value $6.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV7GG
    Delivery Order

This federal contract award, valued at $6,894.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of "TESTOSTERONE 1.62% (2.5 G) PKT UD 2.5GM" pharmaceutical products. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 24, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This contract award is part of Amerisourcebergen's extensive portfolio of federal contracts, demonstrating the company's key role in supplying medical products to various government agencies, including the Department of Justice Federal Bureau of Investigation.

Generated 3/24/25, 9:45 AM